BioIndustry Association appoints new chief executive

Steve Bates will take up the role on 2 July

The new chief executive of the UK’s BioIndustry Association is Steve Bates, who has worked both in biotech and the UK government for 15 years.

Bates was senior director of External Affairs and Market Access at Genzyme UK and Ireland, where he worked on setting up the Office for Life Science and was a member of the BIA’s Communications Advisory Committee. Prior to joining the industry he was special advisor to John Reid MP when Reid was Home Secretary, Secretary of State for Health, Northern Ireland Secretary and Defence Secretary.

Tim Edwards, BIA chairman, said: ‘We are delighted that Steve is joining the BIA. I am certain that his experience in the bioscience sector and within government will prove to be invaluable. Steve will work with BIA members to engage government on our policy initiatives, such as the Citizens Innovation Fund, and to ensure that the Government delivers on the Strategy for UK Life Sciences.

‘I would also like to express the BIA's gratitude to Glyn Edwards for his contribution to the BIA as interim chief executive.’

You may also like

Research & Development

The power of national collaboration

To expedite the scale-up and production of a COVID-19 vaccine, the UK BioIndustry Association issued a call to arms to its members, reports Steve Bates, CEO
Regulatory

Waiting in the shadow of a no deal Brexit

Pharmaceutical companies still do not know how they will be impacted by Brexit after Prime Minister Theresa May decided to postpone a vote on her deal with the European Union (EU), writes Paul Brooks, Executive Director, RAPS
Media

Life Sciences sector responds to report on the impact of Brexit

The Business, Energy and Indsutrial Strategy (BEIS) Committee report calls on the Government to secure a post-Brexit deal to protect patients and the UK's pharmaceutical industry
Regulatory

Life Sciences Industrial Strategy paves way to support UK bioscience growth

The BioIndustry Association (BIA) welcomes the publication of the Life Sciences Industrial Strategy
Media

BIA report shows UK is on track to build the world’s third global biotech cluster

CEO Steve Bates attributes this to an “entrepreneurial and resilient community that is staffed by great management teams”
Media

Triggering Article 50

On 29th March, the UK government triggered Article 50 which officially marks the start of the UK’s exit from the European Union. Home to a world-leading life science industry, the countdown of Britain leaving the EU has inevitably created a stir within the UK’s pharmaceutical industry
Regulatory

BIA explore options for working with EU post-Brexit

The UK BioIndustry Association will send a delegation to Switzerland, to learn from their outside-of-EU system
Subscribe now